Literature DB >> 33264624

Multiple Alternative Promoters and Alternative Splicing Enable Universal Transcription-Based Logic Computation in Mammalian Cells.

Jiten Doshi1, Katie Willis1, Angela Madurga1, Christoph Stelzer1, Yaakov Benenson2.   

Abstract

Multi-input logic gene circuits can enable sophisticated control of cell function, yet large-scale synthetic circuitry in mammalian cells has relied on post-transcriptional regulation or recombinase-triggered state transitions. Large-scale transcriptional logic, on the other hand, has been challenging to implement. Inspired by a naturally found regulatory strategy of using multiple alternative promoters, followed by alternative splicing, we developed a scalable and compact platform for transcriptional OR logic using inputs to those promoters. The platform is extended to implement disjunctive normal form (DNF) computations capable of implementing arbitrary logic rules. Specifically, AND logic is implemented at individual promoters using synergistic transcriptional inputs, and NOT logic via microRNA inputs targeting unique exon sequences driven by those promoters. Together, these regulatory programs result in DNF-like logic control of output gene expression. The approach offers flexibility for building complex logic programs in mammalian cells.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNF logic; OR logic; alternative promoters; alternative splicing; biomolecular computing; gene circuits; gene therapy vectors; mammalian cells; polychromatic reporters; synthetic biology

Mesh:

Year:  2020        PMID: 33264624     DOI: 10.1016/j.celrep.2020.108437

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  3 in total

1.  Design of Gene Boolean Gates and Circuits with Convergent Promoters.

Authors:  Biruck Woldai Abraha; Mario Andrea Marchisio
Journal:  Methods Mol Biol       Date:  2023

2.  Differential regulation of alternative promoters emerges from unified kinetics of enhancer-promoter interaction.

Authors:  Jingyao Wang; Shihe Zhang; Hongfang Lu; Heng Xu
Journal:  Nat Commun       Date:  2022-05-17       Impact factor: 17.694

Review 3.  Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One?

Authors:  Francisco Gimeno-Valiente; Gerardo López-Rodas; Josefa Castillo; Luis Franco
Journal:  Cancers (Basel)       Date:  2022-01-22       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.